Insmed Inc (NASDAQ: INSM) kicked off on Tuesday, up 2.15% from the previous trading day, before settling in for the closing price of $74.09. Over the past 52 weeks, INSM has traded in a range of $21.92-$80.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 275.45% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -0.69%. With a float of $174.44 million, this company’s outstanding shares have now reached $178.90 million.
In an organization with 912 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 76.51%, operating margin of -214.11%, and the pretax margin is -251.01%.
Insmed Inc (INSM) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 2.50%, while institutional ownership is 105.21%. The most recent insider transaction that took place on Sep 13 ’24, was worth 2,072,223. In this transaction Chief Legal Officer of this company sold 27,871 shares at a rate of $74.35, taking the stock ownership to the 67,856 shares. Before that another transaction happened on Sep 13 ’24, when Company’s Chief Medical Officer sold 26,969 for $74.90, making the entire transaction worth $2,019,978. This insider now owns 106,134 shares in total.
Insmed Inc (INSM) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -1.28 earnings per share (EPS), lower than consensus estimate (set at -1.13) by -0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.69% per share during the next fiscal year.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Take a look at Insmed Inc’s (INSM) current performance indicators. Last quarter, stock had a quick ratio of 5.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 39.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.56, a number that is poised to hit -1.18 in the next quarter and is forecasted to reach -4.34 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Let’s dig in a bit further. During the last 5-days, its volume was 1.53 million. That was inferior than the volume of 2.24 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 85.90%. Additionally, its Average True Range was 2.91.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 69.05%, which indicates a significant decrease from 93.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.05% in the past 14 days, which was higher than the 38.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.10, while its 200-day Moving Average is $54.97. However, in the short run, Insmed Inc’s stock first resistance to watch stands at $76.61. Second resistance stands at $77.55. The third major resistance level sits at $79.09. If the price goes on to break the first support level at $74.13, it is likely to go to the next support level at $72.59. The third support level lies at $71.65 if the price breaches the second support level.
Insmed Inc (NASDAQ: INSM) Key Stats
The company with the Market Capitalisation of 13.54 billion has total of 178,903K Shares Outstanding. Its annual sales at the moment are 305,210 K in contrast with the sum of -749,570 K annual income. Company’s last quarter sales were recorded 93,430 K and last quarter income was -220,520 K.
